This inventor holds 2 USPTO granted patents. Top assignees: Health Protection Agency, Imperial College Innovations Limited. Active years: 2006-2007.
Company Filing History:
2 out of 38 
1 out of 173 
Years Active: 2006-2007
Title: John Simon Kroll: Innovator in Vaccine Development
Introduction
John Simon Kroll is a notable inventor based in Oxford, GB. He has made significant contributions to the field of microbial infection treatment, particularly in the development of vaccine compositions. With a total of 2 patents, Kroll's work focuses on innovative methods to combat meningococcal disease.
Latest Patents
Kroll's latest patents include "Neisserial vaccine compositions and methods." These patents describe methods and compositions for the treatment of microbial infections, specifically targeting meningococcal disease. The compositions involve a commensal or an extract of a commensal, which express genes from virulent strains and/or heterologous gene products from non-neisserial sources. Such compositions are utilized in vaccine preparations aimed at treating microbial infections.
Career Highlights
Throughout his career, Kroll has worked with esteemed organizations such as the Health Protection Agency and Imperial College Innovations Limited. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kroll has collaborated with notable colleagues, including Cliona Anne O'Dwyer and Keith Cartwright. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
John Simon Kroll is a distinguished inventor whose work in vaccine development has the potential to significantly improve treatment options for microbial infections. His innovative approaches and collaborations continue to shape the future of medical science.